Sangam Health Care submits FY26 annual report to BSE
- Sangam Health Care Products Limited submitted its FY26 annual report to the BSE
- The filing was made on September 8, 2026, pursuant to SEBI Regulation 34
- Soft copies of the 32nd AGM notice were emailed to registered members
- Bhagt Reddy Dundumulla, Managing Director, signed the regulatory submission

*this image is generated using AI for illustrative purposes only.
Sangam Health Care Products Limited submitted its annual report for FY26 to the Bombay Stock Exchange on September 8, 2026. The filing marks the completion of the company's statutory reporting obligations for the fiscal year.
The company dispatched soft copies of the notice for its 32nd Annual General Meeting along with the annual report to members who have registered their email addresses with the company or depositories. This disclosure was made pursuant to Regulation 34 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Bhagt Reddy Dundumulla, Managing Director of Sangam Health Care Products Limited, signed the communication. The submission serves as an informational record for the exchange regarding the company's compliance with listing regulations.
What specific financial performance metrics or strategic initiatives will be highlighted in the upcoming 32nd Annual General Meeting?
How might Sangam Health Care's FY26 results influence investor sentiment and stock valuation in the near term?
Are there any pending regulatory approvals or compliance issues that could impact the company's operations following this filing?




























